2 results match your criteria: "Department of Scientific and Clinical Affairs Medifast[Affiliation]"
Obes Sci Pract
February 2024
Department of Scientific and Clinical Affairs Medifast, Inc. Baltimore Maryland USA.
Objective: There is substantial inter-individual variability in response to weight loss interventions and emerging evidence suggests that weight loss during the early weeks of an intervention may be predictive of longer-term weight loss. This secondary analysis of data from a commercial program therefore examined 1) the associations between early weight loss (i.e.
View Article and Find Full Text PDFObes Sci Pract
February 2019
Biofortis, Mérieux NutriSciences Addison IL USA.
Objective: Lifestyle interventions remain the cornerstone for obesity treatment. Commercial programs offer one weight loss approach, yet the efficacy of few such programs have been rigorously investigated. The purpose of this study was to evaluate the efficacy of two commercial weight-loss programs, both utilizing pre-portioned meal replacements (MRs) and different levels of behavioural support, compared to a self-directed control diet in adults with overweight and obesity.
View Article and Find Full Text PDF